Colombia Allows Medicinal Cannabis for Local Market

Cannabis Business Times, March 23, By Diana Delgado

The Colombian government issued a new regulation that establishes the regulatory framework to commercialize master cannabis preparations for Colombian medicinal cannabis, a market estimated to comprise some 5 million patients. On March 2, the Ministry of Health issued Resolution 315, which not only opens up the Colombian market for medicinal cannabis but also allows the transformation of dry cannabis flower into derivative products for companies that set up industries at free trade zones. …

“The resolution benefits the sector because it provides clarity on narcotic drugs, psychotropic substances and precursors that are subjected to be controlled, and differentiates them from those that do not require oversight,” Rodrigo Arcilla, director of the Colombian cannabis association Asocolcanna told Cannabis Business Times. …

he resolution allows patients to access cannabis tablets, capsules, gelatinous cubes, gels, oils, creams, suppositories, patches and liquid or gel based on cannabis.

The law also allows doctors who receive training to recommend medical cannabis to patients with several qualifying conditions, mainly chronic or intractable pain, pain related to cancer and terminal illnesses, Parkinson’s disease, multiple sclerosis, epilepsy, tumors and insomnia, among others. …

The Colombian-Canadian company PharmaCielo said the medicinal market will take some time to fully develop “as the industry must continue to develop appropriate treatments and the medical community (doctors) must continue to be educated about medicinal cannabis,” David Gordon, chief commercial officer of PharmaCielo said. Gordon noted that the new resolution is a significant step forward in helping patients get improved while broader access to medicinal cannabis treatment. Pharmacielo has 12.1 hectares (1.3 million square feet) in cannabis production to tap the local and foreign market. …

Read more.